TY - JOUR
T1 - A roadmap to disentangle the molecular etiology of schizophrenia
AU - Falkai, Peter
AU - Mike, Owen
AU - Inez, Germeys
AU - Paul, Harrison
AU - Andras, Bilkei Gorzo
AU - Sophia, Frangou
AU - MEOS Consortium, Consortium
AU - Sophia, Frangou
AU - Andras, Bilkei Gorzo
AU - István, Bitter
AU - Benedicto, Crespo Facorro
AU - De Hert, Marc
AU - Thomas, Dierks
AU - Di Giorgio, Annabella
AU - Albert, Gjedde
AU - Harrison, Paul J.
AU - Siegfried, Kasper
AU - Stephen, Lawrie
AU - Marion, Leboyer
AU - Wolfgang, Maier
AU - Eduard, Maron
AU - McGuire, Philip
AU - Andreas, Meyer Lindenberg
AU - Markus, Nöthen
AU - Mike, Owen
AU - Stephan, Ruhrmann
AU - Franck, Schürhoff
AU - Sagiv, Shifman
AU - Nicholas, Stefanis
AU - van Haren, Neeltje
AU - Elisabett, Vaudano
AU - Antonio, Vita
N1 - Funding Information:
Two calls of the 6FTP-EU initiated intense activity among those European groups with a major interest in schizophrenia research. Several grant proposals were submitted but only the one around DECODE was funded. Subsequently a workshop sponsored by the European Science Foundation (ESF) took place at the Institute of Psychiatry in London at 26th of October 2007. During the 1 day workshop the topics genetics, epidemiology, molecular neuropathology, animal models and imaging were discussed. For each topic, one leading expert gave a 15-min introduction trying to answer the following questions within their special area of interest:
PY - 2008/6/1
Y1 - 2008/6/1
N2 - Schizophrenia is a severe mental disorder striking mainly young adults and leading to life-long disability in a substantial portion of the sufferers. On the other hand, substantial knowledge about its etiology and pathogenesis is still lacking. Therefore the European Science Foundation (ESF) sponsored a meeting of a panel of European experts on schizophrenia research to discuss the state of art and future perspectives of key topics in this area. The fields covered genetics, epidemiology, animal models, molecular neuropathology and imaging. This was a first step to establish a network of European groups dedicated to Schizophrenia research. The coming calls of the frame work program will be used to strengthen this network in order to achieve substantial progress in understanding and treating this devastating illness.
AB - Schizophrenia is a severe mental disorder striking mainly young adults and leading to life-long disability in a substantial portion of the sufferers. On the other hand, substantial knowledge about its etiology and pathogenesis is still lacking. Therefore the European Science Foundation (ESF) sponsored a meeting of a panel of European experts on schizophrenia research to discuss the state of art and future perspectives of key topics in this area. The fields covered genetics, epidemiology, animal models, molecular neuropathology and imaging. This was a first step to establish a network of European groups dedicated to Schizophrenia research. The coming calls of the frame work program will be used to strengthen this network in order to achieve substantial progress in understanding and treating this devastating illness.
KW - Animal models
KW - Development of pharmacotropic agents from target proteins
KW - Epidemiology
KW - Gene-environment interaction
KW - Genetic of psychiatric illnesses
KW - Genetics
KW - Genetics, function of susceptibility genes
KW - Imaging
KW - Imaging and bipolar disorders
KW - Imaging and early recognition
KW - Imaging, molecular neuropathology
KW - Large-scale clinical studies on schizophrenia
KW - Molecular neuropathology, function of susceptibility genes
UR - https://www.scopus.com/pages/publications/46849107340
U2 - 10.1016/j.eurpsy.2008.02.006
DO - 10.1016/j.eurpsy.2008.02.006
M3 - Article
C2 - 18583106
AN - SCOPUS:46849107340
SN - 0924-9338
VL - 23
SP - 224
EP - 232
JO - European Psychiatry
JF - European Psychiatry
IS - 4
ER -